PROTAMINE SULFATE

Clinical safety rating: safe

Animal studies have demonstrated safety

How it works

Protamine sulfate is a cationic protein that binds to heparin, an anionic anticoagulant, forming a stable complex that neutralizes heparin's anticoagulant activity. It also has mild anticoagulant properties of its own.

What the body does with it

Metabolism	Protamine sulfate is rapidly metabolized in the plasma, though the exact metabolic pathways are not fully characterized. It is thought to be cleared by the reticuloendothelial system.
Excretion	Primarily renal excretion (heparin-protamine complexes are cleared by the reticuloendothelial system; elimination is largely independent of renal function). <5% excreted unchanged in urine.
Half-life	Complex with heparin: 4–5 minutes (free protamine: 7.4 minutes). Clinically, the anticoagulant reversal effect is rapid but may be transient due to heparin rebound.
Protein binding	None significant; protamine binds to heparin, not plasma proteins.
Volume of Distribution	Approximately 5 L (0.07 L/kg) – limited to plasma volume due to positive charge and rapid binding to heparin.
Bioavailability	Not applicable; only administered intravenously. Bioavailability: 100% IV.
Onset of Action	Intravenous: immediate (<1 minute) neutralization of heparin. Subcutaneous: not applicable; must be given IV.
Duration of Action	Approximately 2 hours (depending on heparin dose and half-life). Heparin rebound may occur 1–2 hours after initial reversal.

Classification & Brands

Dosing & administration

1 mg IV per 100 units of heparin to be neutralized, administered slowly (not exceeding 5 mg/min) with continuous monitoring. Maximum single dose: 50 mg.

Dosage form	Injectable
Renal impairment	No specific GFR-based adjustment. Use with caution in renal impairment due to potential accumulation; monitor coagulation parameters.
Liver impairment	No specific Child-Pugh based adjustment. Use with caution in severe hepatic impairment due to altered clotting factors.
Pediatric use	1 mg IV per 100 units of heparin to be neutralized, administered slowly (over 1-3 minutes). Maximum: 50 mg per dose. Adjust based on heparin dose and aPTT.
Geriatric use	No specific dose adjustment. Use lower end of dosing range and monitor closely due to increased risk of bleeding and hypersensitivity reactions.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

No significant drug interactions Can cause severe hypotension and anaphylaxis.

Breastfeeding	It is unknown whether protamine sulfate is excreted in human breast milk. Due to its large molecular size and protein nature, excretion into milk is likely minimal. Caution should be exercised. M/P ratio is not available.
Teratogenic Risk	Protamine sulfate is a heparin antagonist derived from fish sperm; it is a large protein that does not cross the placenta in significant amounts. Animal reproduction studies have not been conducted. In humans, there are no adequate data on fetal risk. Use during pregnancy only if clearly needed. There is no known teratogenic risk in any trimester.

Warnings & precautions

■ FDA Black Box Warning

None

Side Effect Profile

Common Effects	Hypotension
Serious Effects

Absolute Contraindications

["Known hypersensitivity to protamine sulfate","Severe hypotension or cardiovascular instability (relative)"]

Clinical Precautions

Precautions

["Risk of hypersensitivity reactions including anaphylaxis, especially in patients with fish allergies, previous exposure to protamine, or vasectomized males","Hypotension and bradycardia may occur with rapid administration","May cause transient anticoagulation at high doses","Monitor coagulation parameters (e.g., activated clotting time) during administration"]

Clinical Tips & Counseling

Drug interactions

Loading safety data…